Cargando…
AB112. Expression of brain-specific angiogenesis inhibitor 1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma
OBJECTIVE: Brain-specific angiogenesis inhibitor 1 (BAI1) was initially described in 1997, and there have since been a number of studies on its expression in different types of cancer. The aim of the present study was to investigate the expression levels of BAI1 in bladder transitional cell carcinom...
Autores principales: | Tian, Dawei, Hu, Hailong, Wu, Changli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842571/ http://dx.doi.org/10.21037/tau.2016.s112 |
Ejemplares similares
-
AB111. Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population
por: Zhang, Yu, et al.
Publicado: (2016) -
AB058. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016) -
Role of Microvessel Density and Vascular Endothelial Growth Factor in Angiogenesis of Hematological Malignancies
por: Chand, Rashika, et al.
Publicado: (2016) -
AB110. In vitro evaluation of endothelial progenitor cells from adipose tissue as potential angiogenic cell sources for bladder angiogenesis
por: Zhou, Liuhua, et al.
Publicado: (2016) -
Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
por: Barbosa, Daniella FL, et al.
Publicado: (2013)